» Articles » PMID: 17220916

Activating and Inhibitory Functions of DAP12

Overview
Journal Nat Rev Immunol
Date 2007 Jan 16
PMID 17220916
Citations 120
Authors
Affiliations
Soon will be listed here.
Abstract

When associated with different receptors, the signalling adaptor DAP12 has been shown to both potentiate and attenuate the activation of leukocytes. But how can a protein with a single signalling motif elicit qualitatively different cellular responses? We describe a model of DAP12 function, whereby the quality of the cellular response (activation or inhibition) is modulated by the avidity of the interaction between the DAP12-associated receptor and its ligand. This model extends from previous studies of inhibitory signalling mediated by other adaptors, such as the Fc-receptor gamma-chain and CD3zeta, and provides a potential mechanism for the conflicting phenotypes observed in studies of DAP12-deficient mice.

Citing Articles

Pooled screening for CAR function identifies novel IL-13Rα2-targeted CARs for treatment of glioblastoma.

Gordon K, Perez C, Garmilla A, Lam M, Aw J, Datta A J Immunother Cancer. 2025; 13(2).

PMID: 39933837 PMC: 11815465. DOI: 10.1136/jitc-2024-009574.


Role of triggering receptor expressed on myeloid cells-1 in kidney diseases: A biomarker and potential therapeutic target.

Fan Y, Xu Y, Huo Z, Zhang H, Peng L, Jiang X Chin Med J (Engl). 2024; 137(14):1663-1673.

PMID: 38809056 PMC: 11268828. DOI: 10.1097/CM9.0000000000003197.


TYROBP/DAP12 knockout in Huntington's disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deterioration.

Creus-Muncunill J, Haure-Mirande J, Mattei D, Bons J, Ramirez A, Hamilton B J Neuroinflammation. 2024; 21(1):66.

PMID: 38459557 PMC: 10924371. DOI: 10.1186/s12974-024-03052-4.


Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohort.

Parodis I, Lindblom J, Barturen G, Ortega-Castro R, Cervera R, Pers J Ann Rheum Dis. 2024; 83(7):889-900.

PMID: 38373843 PMC: 11187369. DOI: 10.1136/ard-2023-224795.


Signal regulatory protein beta 2 is a novel positive regulator of innate anticancer immunity.

Visser N, Nelemans L, He Y, Lourens H, Corrales M, Huls G Front Immunol. 2023; 14:1287256.

PMID: 38116002 PMC: 10729450. DOI: 10.3389/fimmu.2023.1287256.